Mr. Alp Atay, Director of Astellas Asia - Pacific, commented that focusing on converting inventoryed pharmaceuticals into practical values for patients has been the strategic vision of the group since its inception.
Astellas brings to Vietnam a diverse range of transplant drugs, oncology and urine. The company is developing new drug lines to treat advanced cancer, women's health and ophthalmology. Director of Alp Atay believes that the above focus can help them realize the aspiration of " bringing the best treatment to Vietnamese patients".
Mr. Alp Atay assessed the business's development speed as very positive, bringing many values to patients, and pointed out that the high demand for health care in our country requires increasingly improved product quality and supply.
The company also continuously improves product supply capacity, raises awareness of pathology, ensuring that patients can access new treatment methods in a timely manner. This requires close cooperation with the medical community including organizations, associations, medical experts and universities.
